XABREX Trademark
Trademark Overview
On Friday, January 31, 2003, a trademark application was filed for XABREX with the United States Patent and Trademark Office. The USPTO has given the XABREX trademark a serial number of 78209740. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, February 27, 2004. This trademark is owned by Corixa Corporation. The XABREX trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceuticals for the treatment of cancer
General Information
Serial Number | 78209740 |
Word Mark | XABREX |
Filing Date | Friday, January 31, 2003 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Friday, February 27, 2004 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | pharmaceuticals for the treatment of cancer |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, February 27, 2003 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Corixa Corporation |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Seattle, WA 981042040 |
Trademark Events
Event Date | Event Description |
Friday, February 27, 2004 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Tuesday, July 22, 2003 | NON-FINAL ACTION MAILED |
Friday, July 18, 2003 | NON-FINAL ACTION E-MAILED |
Friday, July 18, 2003 | ASSIGNED TO EXAMINER |